Skip to main content

DJS Law Group

Beta Bionics Faces Securities Fraud Suit Over iLet Pump Disclosures

Los Angeles – September 10, 2026 -- DJS Law Group has reminded shareholders of a class action lawsuit filed against Beta Bionics, Inc. (NASDAQ: BBNX) alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The suit covers investors who purchased BBNX shares between July 30, 2025 and February 24, 2026, with a lead plaintiff filing deadline set for November 3, 2026.

Complaint alleges Beta Bionics downplayed FDA findings on its iLet insulin pump

The complaint centers on the iLet Bionic Pancreas insulin pump, Beta Bionics' sole commercialized product. After the company disclosed that the FDA had issued a Form 483 following a manufacturing facility inspection, defendants allegedly told investors the agency's observations were limited to complaint-reporting criteria and did not reflect underlying device problems.

GPGI Faces Securities Fraud Suit Over Husky Acquisition Claims

Los Angeles – September 10, 2026 -- DJS Law Group has issued a reminder to investors of a securities class action lawsuit against GPGI, Inc., formerly known as CompoSecure, Inc. (NYSE: GPGI), with a lead plaintiff deadline set for September 15, 2026.

Lawsuit alleges GPGI misled investors over Husky Technologies deal

The complaint alleges GPGI violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, along with SEC Rule 10b-5, by making false and misleading statements to the market. According to the filing, GPGI's acquisition of Husky Technologies Limited was structured to benefit related parties and company insiders rather than shareholders.